BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24815845)

  • 1. Survival and prognostic factors in adult patients with recurrent or refractory ewing sarcoma family tumours: a 13-years retrospective study in Turkey.
    Yildiz I; Sen F; Ekenel M; Darendeliler E; Bavbek S; Agaoglu F; Ozger H; Eralp L; Bilgic B; Basaran M
    In Vivo; 2014; 28(3):403-9. PubMed ID: 24815845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of patients with recurrent or refractory localized Ewing's sarcoma family of tumors: A retrospective report from the Japan Ewing Sarcoma Study Group.
    Umeda K; Miyamura T; Yamada K; Sano H; Hosono A; Sumi M; Okita H; Kumamoto T; Kawai A; Hirayama J; Jyoko R; Sawada A; Nakayama H; Hosoya Y; Maeda N; Yamamoto N; Imai C; Hasegawa D; Chin M; Ozaki T;
    Cancer Rep (Hoboken); 2021 Jun; 4(3):e1329. PubMed ID: 33452866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study.
    van Maldegem AM; Benson C; Rutkowski P; Blay JY; van den Berg H; Placzke J; Rasper M; Judson I; Juergens H; Dirksen U; Gelderblom H
    Pediatr Blood Cancer; 2015 Jan; 62(1):40-4. PubMed ID: 25251256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience.
    Orr WS; Denbo JW; Billups CA; Wu J; Navid F; Rao BN; Davidoff AM; Krasin MJ
    Ann Surg Oncol; 2012 Nov; 19(12):3816-22. PubMed ID: 22739653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol.
    Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Mohanti BK; Sharma MC; Vishnubhatla S; Bakhshi S
    J Surg Oncol; 2015 May; 111(6):683-9. PubMed ID: 25557999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
    Tural D; Molinas Mandel N; Dervisoglu S; Oner Dincbas F; Koca S; Colpan Oksuz D; Kantarci F; Turna H; Selcukbiricik F; Hiz M
    Jpn J Clin Oncol; 2012 May; 42(5):420-6. PubMed ID: 22416252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose chemotherapy and autologous peripheral blood stem-cell transfusion after conventional chemotherapy for patients with high-risk Ewing's tumors.
    Tanaka K; Matsunobu T; Sakamoto A; Matsuda S; Iwamoto Y
    J Orthop Sci; 2002; 7(4):477-82. PubMed ID: 12181663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of recurrence and survival after relapse in patients with Ewing sarcoma.
    Stahl M; Ranft A; Paulussen M; Bölling T; Vieth V; Bielack S; Görtitz I; Braun-Munzinger G; Hardes J; Jürgens H; Dirksen U
    Pediatr Blood Cancer; 2011 Oct; 57(4):549-53. PubMed ID: 21442722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group.
    Cotterill SJ; Ahrens S; Paulussen M; Jürgens HF; Voûte PA; Gadner H; Craft AW
    J Clin Oncol; 2000 Sep; 18(17):3108-14. PubMed ID: 10963639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult Ewing sarcoma: survival and local control outcomes in 36 patients with metastatic disease.
    Ahmed SK; Robinson SI; Okuno SH; Rose PS; Issa Laack NN
    Am J Clin Oncol; 2014 Oct; 37(5):423-9. PubMed ID: 23388557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of prognostic factors of pediatric-type sarcomas in adult patients.
    Ahn HK; Uhm JE; Lee J; Lim DH; Seo SW; Sung KS; Lee SJ; Lee DJ; Baek KK; Kim WS; Park JO
    Oncology; 2011; 80(1-2):21-8. PubMed ID: 21606660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol.
    Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Sharma DN; Thulkar S; Vishnubhatla S; Pathania S; Bakhshi S
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):722-9. PubMed ID: 24919857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology.
    Arpaci E; Yetisyigit T; Seker M; Uncu D; Uyeturk U; Oksuzoglu B; Demirci U; Coskun U; Kucukoner M; Isıkdogan A; Inanc M; Alkis N; Ozkan M
    Med Oncol; 2013 Mar; 30(1):469. PubMed ID: 23345116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group - EWING1.
    Becker RG; Gregianin LJ; Galia CR; Jesus-Garcia Filho R; Toller EA; Badell G; Nakagawa SA; David A; Baptista AM; Yonamime ES; Serafini OA; Penna V; Santos JFC; Brunetto AL;
    BMC Cancer; 2017 Jun; 17(1):420. PubMed ID: 28619077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma.
    Shankar AG; Ashley S; Craft AW; Pinkerton CR
    Med Pediatr Oncol; 2003 Mar; 40(3):141-7. PubMed ID: 12518341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of adult patients with relapsed Ewing sarcoma: a 30-year single-institution experience.
    Robinson SI; Ahmed SK; Okuno SH; Arndt CA; Rose PS; Laack NN
    Am J Clin Oncol; 2014 Dec; 37(6):585-91. PubMed ID: 23466580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ewing's sarcoma family of tumors in Finland during 1990-2009: a population-based study.
    Serlo JA; Helenius IJ; Sampo M; Vettenranta K; Saarinen-Pihkala UM; Kivivuori SM; Riikonen P; Kivioja A; Böhling T; Kallajoki M; Ristimäki A; Vasama K; Tarkkanen M
    Acta Oncol; 2013 May; 52(4):767-75. PubMed ID: 23173760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after recurrence of Ewing's sarcoma family of tumors.
    Barker LM; Pendergrass TW; Sanders JE; Hawkins DS
    J Clin Oncol; 2005 Jul; 23(19):4354-62. PubMed ID: 15781881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment.
    Argon A; Basaran M; Yaman F; Dizdar Y; Sakar B; Camlica H; Bavbek SE; Ozger H; Darendeliler E; Onat H
    Jpn J Clin Oncol; 2004 Nov; 34(11):667-72. PubMed ID: 15613556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal treatment including standard chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for the Ewing sarcoma family of tumors in Japan: Results of the Japan Ewing Sarcoma Study 04.
    Chin M; Yokoyama R; Sumi M; Okita H; Kawai A; Hosono A; Koga Y; Sano H; Watanabe H; Ozaki T; Mugishima H;
    Pediatr Blood Cancer; 2020 May; 67(5):e28194. PubMed ID: 32077253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.